Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investors Events
  • Pre market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
August 18, 2020 1:20 PM 1 min read

Cantor Upgrades Curaleaf On Q2 Beat, Q3 Guidance

by Priya Nigam Benzinga Staff Writer
Follow
CURLF Logo
CURLFCuraleaf Holdings Inc
$2.20-4.34%
Overview

Curaleaf Holdings Inc. (OTCQX:CURLF) reported healthy results for the second quarter and announced upbeat guidance for the third quarter, according to Cantor Fitzgerald.

The Curaleaf Analyst: Pablo Zuanic upgraded the rating for Curaleaf Holdings from Neutral to Overweight, while raising the price target from $10 to $18.

The Curaleaf Thesis: The company’s third-quarter sales guidance is 15% higher than Cantor’s estimate and implied 20-25% upside to fourth-quarter point, Zuanic said in the upgrade note.

Curaleaf doubled its capacity in key states, partly fueled by continued investment, the acquisition of Grassroots and the ongoing national rollout of the Select brand, the analyst mentioned.

He added that the company is accelerating its capacity expansion at a time when its peers are scaling down. Zuanic further noted that Curaleaf has a presence in 23 states and seeks to build “nationally recognized brands.”

However, the analyst expects the stock’s outperformance will be driven by having leadership in states like Massachusetts and Illinois, which are fast growing restricted recreational markets. He added that several of the states, like Arizona, New York, New Jersey and Connecticut, could go recreational.

Moreover, the company’s plans in Florida “offer further optionality upside,” Zuanic wrote.

CURLF Price Action: Shares of Curaleaf Holdings were trading around $9.20 at the time of publication.

Related Links
Benzinga's Top Upgrades, Downgrades For August 18, 2020
Cannabis Stock Gainers And Losers From August 17, 2020

 

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.


Posted In:
Analyst ColorUpgradesPrice TargetAnalyst RatingsCantor FitzgeraldPablo Zuanic
CURLF Logo
CURLFCuraleaf Holdings Inc
$2.20-4.34%
Overview
Comments
Loading...